Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $22.34 USD
Change Today +0.15 / 0.68%
Volume 769.4K
EXAS On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Graham P. Lidgard Ph.D.

Chief Science Officer and Senior Vice President,Exact Sciences Corporation
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

As of Fiscal Year 2014


Dr. Graham P. Lidgard, Ph.D., has been the Chief Science Officer and Senior Vice President of Exact Sciences Corp. since August 2009. Dr. Lidgard served as Senior Vice President of Research & Development at Nanogen Inc., a holding company of Synx Pharma Inc. from January 2003 to August 2009. At Nanogen, he managed its point of care and molecular diagnostics research and development groups. Dr. Lidgard joined Nanogen in January 2003 and has over 30 years of experience ...

Read Full Background

Corporate Headquarters*

441 Charmany Drive
Madison, Wisconsin 53719

United States

Phone: 608-284-5700
Fax: 608-284-5701

Board Members Memberships*

There is no Board Members Memberships data available.


University of Manchester
University of Manchester
Bachelor's Degree
University of Manchester
University of Manchester

Other Affiliations*

Annual Compensation*

Total Annual Compensation$518,381

Stock Options*

Restricted Stock Awards$460,680
All Other Compensation$15,600
Exercised Options225,000
Exercised Options Value$4,699,000
Exercisable Options411,125
Exercisable Options Value$9,856,335
Unexercisable Options102,875
Unexercisable Options Value$1,608,140
Total Value of Options$16,163,475
Total Number of Options739,000

Total Compensation*

Total Annual Cash Compensation$533,981
Total Short Term Compensation$518,381
Other Long Term Compensation$476,280
Total Calculated Compensation$1,458,054
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXAS:US $22.34 USD +0.15


Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
Ricardo J. Gonzalez Chief Executive Officer, President and Director
Navidea Biopharmaceuticals, Inc
Anthony S. Marucci M.B.A.Founder, Chief Executive Officer, President and Director
Celldex Therapeutics, Inc.
Laurence James Neil Cooper Ph.D., M.D.Chief Executive Officer
ZIOPHARM Oncology, Inc.
Michael R. Stewart Chief Executive Officer, President and Director
MELA Sciences, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXACT SCIENCES CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at